Skip to main content
. 2009 Jan;67(1):125–129. doi: 10.1111/j.1365-2125.2008.03333.x

Table 2.

The diclofenac concentration in each tissue

Group Patient Fat Muscle Synovial membrane Plasma Synovial fluid
Topical application 1 4.757 <LOQ 3.15 6.209 2.994
2 2.45 10.776 6.626 3.566 1.718
3 20.47 <LOQ <LOQ 3.364 1.8
4 6.03 8.911 6.844 5.133 2.851
5 6.953 6.632 2.886 1.783 1.325
6 32.655 23.359 11.899 7.608 1.524
7 20.894 15.381 3.535 5.252 1.504
Mean 13.46 9.29 4.99 4.70 1.96
SD 11.31 8.34 3.84 1.95 0.68
5% CI 3.35 1.84 1.55 2.96 1.35
95% CI 16.81 11.14 6.55 7.66 3.31
Oral application 8 4.236 <LOQ 6.695 4.242 8.301
9 2.946 <LOQ 11.242 5.069 15.747
10 6.494 3.167 16.166 5.255 7.858
11 1.857 <LOQ 12.413 3.415 17.233
12 <LOQ <LOQ 4.787 2.37 2.655
13 5.907 <LOQ 24.232 11.728 32.485
14 5.276 <LOQ 29.965 14.335 33.064
Mean 3.85 0.66 15.07 6.63 16.76
SD 2.28 1.11 9.17 4.54 12
5% CI 1.72 −0.62 6.87 2.57 6.04
95% CI 5.54 −0.17 21.95 9.20 22.80
Comparisons between the two groups P-value 0.0476 0.0196 0.0181 0.6547 0.004

The quantification limit (<LOQ) value was 0.24 ng g−1 for fat, muscle and synovial tissue, and 0.4 ng ml−1 for synovial fluid and blood plasma. For samples in which the diclofenac level was below the <LOQ, zero was used to calculate the mean and the standard deviation (SD).